Age, time to diagnosis predict PML survival
Age, time to diagnosis predict PML survival
Younger age, faster diagnosis, and undergoing treatment in Europe were among the factors associated with greater likelihood of survival in cases of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis patients treated with natalizumab (Tysabri), a researcher reported here.
Analysis of the first 79 cases of PML in patients receivingnatalizumab found that these were the strongest survival predictors, according to John Foley, MD, of the Rocky Mountain Multiple Sclerosis Clinic in Salt Lake City............. Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1768
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1185 Views
-
Last post by frodo
-
- 1 Replies
- 1582 Views
-
Last post by ElliotB
-
- 0 Replies
- 191 Views
-
Last post by frodo
-
- 0 Replies
- 2846 Views
-
Last post by frodo
-
- 0 Replies
- 2040 Views
-
Last post by frodo
-
- 0 Replies
- 1411 Views
-
Last post by frodo
-
- 0 Replies
- 1616 Views
-
Last post by frodo
-
- 1 Replies
- 1366 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1467 Views
-
Last post by frodo